One of the fastest growing pharmaceutical companies in the country, MSN Laboratories has nine API facilities, including ones for Cytotoxics and Prostaglandines. Our supply of APIs across the globe has made us a successful business partner and being recognized as a true global player in the pharmaceutical sector. We have made considerable impact in more than 35 therapeutic domains and now serve over 300 customers internationally.
The creme de la creme of our research minds combined with our unique development strategies, operational efficiency and consistent excellence has put us on the map for having achieved dynamic growth. This is owing to our group’s determination in meeting all our customers’ production requirements and timely deliverables.
Today we are #1 in the World in Active US DMF Filings
Our API facilities can manufacture not only synthetic organic small molecules but also fermentation-based products and complex bio similars. We are the leading global experts in synthesizing complex organic compounds.
Our comprehensive product basket consisting of around 350 APIs includes complete range of Oncology, Prostaglandins and more than a dozen Peptides covering 35 therapeutic categories.
Our accomplishments in the area of geographical expansion, specific to facilities are:
As a group, we are self-sustained and backward integrated with all our key starting materials. All critical Key Starting Materials (KSMs) are manufactured in-house. In order to be cost efficient, we are constantly working on cost improvements. More than 200 R&D process experts work at our API plants to support our cost improvement initiatives. We are in absolute compliance with global norms of safety, health and environment and are ISO certified across all our manufacturing sites.
We at MSN Laboratories work tirelessly to grow and to develop our reputation. We currently have:
MSN has to its credit the first generic versions of several drugs in India & other countries. We have created these in multiple forms - in the dosage forms of tablets (IR, SR/ER, Bi-Layered, Chewable, Dispersible and Sublingual), capsules (IR and DR) or injectables in the form of vials and ampoules. Examples of our firsts in the world generics include
Prasugrel | Bosentan | Febuxostat | Tapentadol | Ambrisentan | Lacosamide | Silodosin | Tolvaptan | Asenapine
We at MSN Laboratories work tirelessly to grow and to develop our reputation. We currently have 137 Indian Patents Filed with 82 published, and over 55 PCTs with 45 published ones. Of the 100+ products we have worked so far, we have filed more than 188 patents, and are still counting.